CH618706A5 - - Google Patents

Download PDF

Info

Publication number
CH618706A5
CH618706A5 CH232477A CH232477A CH618706A5 CH 618706 A5 CH618706 A5 CH 618706A5 CH 232477 A CH232477 A CH 232477A CH 232477 A CH232477 A CH 232477A CH 618706 A5 CH618706 A5 CH 618706A5
Authority
CH
Switzerland
Prior art keywords
formula
group
amino
hydrogen atom
compound
Prior art date
Application number
CH232477A
Other languages
English (en)
French (fr)
Inventor
Barry Clive Ross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CH618706A5 publication Critical patent/CH618706A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CH232477A 1976-02-25 1977-02-24 CH618706A5 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (1)

Publication Number Publication Date
CH618706A5 true CH618706A5 (pt) 1980-08-15

Family

ID=9834870

Family Applications (1)

Application Number Title Priority Date Filing Date
CH232477A CH618706A5 (pt) 1976-02-25 1977-02-24

Country Status (26)

Country Link
US (1) US4107435A (pt)
JP (1) JPS52111545A (pt)
AR (1) AR215616A1 (pt)
AT (1) AT348123B (pt)
BE (1) BE851777A (pt)
CA (1) CA1071624A (pt)
CH (1) CH618706A5 (pt)
CS (2) CS195714B2 (pt)
DD (2) DD130150A5 (pt)
DE (1) DE2708008C3 (pt)
DK (1) DK82177A (pt)
EG (1) EG12650A (pt)
ES (1) ES456304A1 (pt)
FI (1) FI770568A (pt)
FR (2) FR2351109A1 (pt)
GB (1) GB1529243A (pt)
GR (1) GR66424B (pt)
HU (1) HU179565B (pt)
IE (1) IE44885B1 (pt)
LU (1) LU76829A1 (pt)
NL (2) NL166265C (pt)
PL (2) PL103737B1 (pt)
PT (1) PT66229B (pt)
RO (1) RO76081A (pt)
SE (1) SE7702066L (pt)
SU (1) SU659092A3 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US8314071B2 (en) * 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1593321A1 (de) * 1962-04-03 1970-04-02 Rit Rech Ind Therapeut Verfahren zur Herstellung von niederen N-Alkylderivaten basischer Antibiotica

Also Published As

Publication number Publication date
DE2708008C3 (de) 1982-04-22
IE44885L (en) 1977-08-25
US4107435A (en) 1978-08-15
FR2351127B1 (pt) 1981-06-12
FR2351109A1 (fr) 1977-12-09
PT66229A (en) 1977-03-01
SU659092A3 (en) 1979-04-25
GR66424B (pt) 1981-03-20
FR2351109B1 (pt) 1981-07-24
IE44885B1 (en) 1982-05-05
FR2351127A1 (fr) 1977-12-09
ES456304A1 (es) 1978-01-16
AR215616A1 (es) 1979-10-31
DE2708008B2 (de) 1981-07-02
RO76081A (ro) 1981-08-17
NL166265C (nl) 1981-07-15
ATA116777A (de) 1978-06-15
LU76829A1 (pt) 1978-10-18
DE2708008A1 (de) 1977-09-01
NL7901693A (nl) 1979-07-31
BE851777A (fr) 1977-08-24
GB1529243A (en) 1978-10-18
SE7702066L (sv) 1977-08-26
CS195715B2 (en) 1980-02-29
JPS52111545A (en) 1977-09-19
EG12650A (en) 1979-06-30
FI770568A (pt) 1977-08-26
CA1071624A (en) 1980-02-12
NL7701980A (nl) 1977-08-29
PL103737B1 (pl) 1979-07-31
PT66229B (en) 1978-07-17
AT348123B (de) 1979-01-25
PL102193B1 (pl) 1979-03-31
CS195714B2 (en) 1980-02-29
DD135200A5 (de) 1979-04-18
NL166265B (nl) 1981-02-16
DK82177A (da) 1977-08-26
DD130150A5 (de) 1978-03-08
HU179565B (en) 1982-11-29

Similar Documents

Publication Publication Date Title
CH618706A5 (pt)
EP0340064B1 (fr) Benzodiazépines, leur procédé et intermédiaires de préparation et leurs applications en thérapeutique
KR100670704B1 (ko) 2-옥사졸리디논유도체의원포트합성
LU81881A1 (fr) Procede de preparation d'un derive n-acyle selectivement protege d'un antibiotique aminoglycosidique
CH622528A5 (en) Process for the preparation of aminoglycoside antibiotics
FR2470774A1 (fr) Derives de nucleosides, leur preparation et leurs utilisations therapeutiques
CH629218A5 (fr) Procede de preparation de derives du glucopyranose-nitrosouree.
FR2500838A1 (fr) Derives de neplanocine a
LU80124A1 (fr) Procede de production de derives 1-n-alkyles de la kanamycine
CH631445A5 (en) Process for the preparation of 2-hydroxymethyl-3-hydroxy-6- (1-hydroxy-2-(t-butylamino)ethyl)pyridine
JP5078108B2 (ja) 糖供与体
FR2493318A1 (fr) Nouveaux derives de nitrosouree
CH628906A5 (en) Semi-synthetic derivatives of 4''-erythromycin A and medicinal products containing them
JP3366723B2 (ja) 脱保護法
FR2467209A1 (fr) Procede de preparation d'anomeres et de melanges asteriques d'analogues de spectinomycine
BE887456R (fr) Procede de production de composes intermediaires pour l'obtention de la spectinomycine et de ses analogues et produits de ce procede
AU728986B2 (en) Process for preparing etoposide
KR820000058B1 (ko) 글루코피라노오스-니트로소우레아 화합물의 제조방법
KR820000144B1 (ko) 아미노글리코사이드 유도체의 제조방법
FR2476652A1 (fr) Derives 3', 4'-anhydro-4'-epi de la kanamycine a et leur procede de preparation
BE879925A (fr) Procede nouveau de preparation d'un derive n-acyle selectivement protege d'un antibiotique amino-glycosidique
FR2460953A1 (fr) Nouveau procede de preparation d'anomeres et de melanges asteriques de nouveaux analogues de spectinomycine
Limberg et al. Synthesis of modified aldonic acids and studies of their substrate efficiency for dihydroxy acid dehydratase (DHAD)
BE472557A (pt)
CH508590A (fr) Procédé de préparation des esters d'alcoyle inférieurs de l'a-L-aspartyl-L-phénylalanine

Legal Events

Date Code Title Description
PL Patent ceased